4.5 Article

Peroxisome Proliferator-Activated Receptor β/δ Cross Talks with E2F and Attenuates Mitosis in HRAS-Expressing Cells

Journal

MOLECULAR AND CELLULAR BIOLOGY
Volume 32, Issue 11, Pages 2065-2082

Publisher

AMER SOC MICROBIOLOGY
DOI: 10.1128/MCB.00092-12

Keywords

-

Funding

  1. National Institutes of Health [CA124533, CA126826, CA141029, CA140369, AA018863, CA122109, CAL117957]
  2. National Cancer Institute Intramural [ZIABC005561, ZIABC005562, ZIABC005708]

Ask authors/readers for more resources

The role of peroxisome proliferator-activated receptor beta/delta (PPAR beta/delta) in Harvey sarcoma ras (Hras)-expressing cells was examined. Ligand activation of PPARI beta/delta caused a negative selection with respect to cells expressing higher levels of the Hras oncogene by inducing a mitotic block. Mitosis-related genes that are predominantly regulated by E2F were induced to a higher level in HRAS-expressing Ppar beta/delta-null keratinocytes compared to HRAS-expressing wild-type keratinocytes. Ligand-activated PPAR beta/delta repressed expression of these genes by direct binding with p130/p107, facilitating nuclear translocation and increasing promoter recruitment of p130/p107. These results demonstrate a novel mechanism of PPAR beta/delta cross talk with E2F signaling. Since cotreatment with a PPAR beta/delta ligand and various mitosis inhibitors increases the efficacy of increasing G(2)/M arrest, targeting PPAR beta/delta in conjunction with mitosis inhibitors could become a suitable option for development of new multitarget strategies for inhibiting RAS-dependent tumorigenesis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available